Rekvina Laboratories Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
- Paid Up Capital ₹ 3.01 Cr
- Company Age 36 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.04 Cr
- Revenue Growth %
- Profit Growth 99.06%
- Ebitda 94.62%
- Net Worth -5.36%
- Total Assets 4.92%
About Rekvina Laboratories
Rekvina Laboratories Limited (RLL) is a Public Limited Indian Non-Government Company incorporated in India on 01 November 1988 and has a history of 36 years and two months. Its registered office is in Baroda, Gujarat, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 526075.
The Corporate was formerly known as Rekvina Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.01 Cr.
The company currently has active open charges totaling ₹8.04 Cr.
Jitendra Doshi, Mahendra Dalal, Vibha Shah, and Two other members serve as directors at the Company.
Company Details
- Location
Baroda, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
L24231GJ1988PLC011458
- Company No.
011458
- Stock Symbol
BSE : 526075
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Nov 1988
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
What products or services does Rekvina Laboratories Limited offer?
Rekvina Laboratories Limited offers a wide range of products and services, including Protein Supplements, Amino Acids.
Who are the key members and board of directors at Rekvina Laboratories?
Board Members (5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jitendra Doshi | Additional Director | 01-Oct-2010 | Current |
Mahendra Dalal | Additional Director | 01-Oct-2010 | Current |
Vibha Shah | Director | 21-Mar-2015 | Current |
Amit Shah | Director | 01-Aug-2000 | Current |
Mukesh Shah | Director | 02-Oct-1997 | Current |
Financial Performance of Rekvina Laboratories.
Rekvina Laboratories Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 99.06% increase in profit. The company's net worth dipped by a decrease of 5.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Rekvina Laboratories?
In 2023, Rekvina Laboratories had a promoter holding of 41.30% and a public holding of 58.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹8.04 Cr
₹0
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 6.95 Cr
- Industrial Devlopment Bank Of India : 0.80 Cr
- Gujrat State Financial Corportion : 0.29 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
30 Dec 2203 | Bank Of Baroda | ₹0.50 M | Open |
13 Jul 1999 | Bank Of Baroda | ₹1.90 Cr | Open |
24 Sep 1997 | Bank Of Baroda | ₹1.90 Cr | Open |
13 Jul 1994 | Bank Of Baroda | ₹1.90 Cr | Open |
10 Dec 1993 | Bank Of Baroda | ₹5.30 M | Open |
How Many Employees Work at Rekvina Laboratories?
Unlock and access historical data on people associated with Rekvina Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rekvina Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rekvina Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.